Harvard Bioscience (HBIO) Acquires AHN Biotechnologie GmbH
HBIO Hot Sheet
EPS Growth %: +28.6%
Harvard Bioscience, Inc. (Nasdaq: HBIO), has acquired the business of AHN Biotechnologie GmbH through its wholly owned Biochrom Ltd. subsidiary.
AHN is a privately held manufacturer of plastic consumable laboratory products including pipette tips. This acquisition is complementary to the current Biochrom product line of molecular biology instruments.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
AHN is a privately held manufacturer of plastic consumable laboratory products including pipette tips. This acquisition is complementary to the current Biochrom product line of molecular biology instruments.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- UPDATE: SAP's (SAP) America Unit to Buy Ariba (ARBA) for $45/Share
- Dell (DELL) Could Be Considering Bid for Quest Software (QSFT)
- Amylin (AMLN) Shares Jump as Bids Due Today, Sanofi (SNY), Merck (MRK) Said to Make First-Round Bids
Create E-mail Alert Related Categories
Mergers and AcquisitionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
